US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,789.34

-2.6739-0.15%

Number of Gainers:1

Number of Losers:1

Number of Flat:- -

PE:- -

High:1,797.33

Open:1,795.07

Low:1,781.55

Close:1,792.01

Volume:7.41M

Turnover:1.11B

Market Cap:461.08B

Float Cap:452.50B

Loading ...

Sat Out Gilead Sciences' Rally? Here Is What Holders Saw

Simply Wall St.

Novartis AG Rises Monday

Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says

MT Newswires Live

Novartis Has Levers to Pull to Offset Next Patent Cliff

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Novartis AG Rises Friday, Outperforms Market

Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Novartis AG Rises Wednesday, Outperforms Market

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS

Novartis price target lowered to $156 from $170 at Morgan Stanley

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live

Cognizant announces five-year extension of its work with Gilead Sciences

Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences

THOMSON REUTERS

Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Novartis AG Rises Monday, Underperforms Market

Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketl.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1789.3386,"timestamp":1791835199999,"preClose":1792.0126,"halted":0,"volume":7405552,"delay":0,"changeRate":-0.001492,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.67395,"latestTime":"10-12 16:00:00 EDT","open":1795.0657,"high":1797.3335,"low":1781.5499,"amount":1106754719.944934,"amplitude":0.008808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.631404,"peRate":48.404609,"turnoverRate":0.002397,"increases":1,"decrements":1,"flats":0,"marketCap":461082148864,"floatMarketCap":452504682496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1797.3335,"amplitude":0.008808,"preClose":1792.0126,"low":1781.5499,"pbRate":"8.631404","latestPrice":1789.3386,"volume":7405552,"delay":0,"open":1795.0657,"prevYearClose":1612.5378,"prevWeekClose":1792.0126,"prevMonthClose":1773.368,"prevQuarterClose":1773.368,"fiveDayClose":1739.2102,"twentyDayClose":1733.9093,"sixtyDayClose":1785.2554,"secType":"PLATE","market":"US","turnoverRate":0.002397,"peRate":48.404609,"marketCap":461082148864,"floatMarketCap":452504682496,"timestamp":1791835199999,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":1,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675387757","title":"Sat Out Gilead Sciences' Rally? Here Is What Holders Saw","url":"https://stock-news.laohu8.com/highlight/detail?id=2675387757","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675387757?lang=en_us&edition=fundamental","pubTime":"2026-10-13 10:22","pubTimestamp":1791858151,"startTime":"0","endTime":"0","summary":"If Gilead Sciences was on your watchlist instead of in your portfolio, the gap may feel a bit raw. For Gilead Sciences shareholders, the return over the past year was 30.4%, including dividends. That outcome forces a simple question. Back on 12 October 2025, when analysts were arguing over whether modest revenue growth and fatter profit margins could justify a higher future P/E, what signals were already on record that this business mix shift might matter more than the policy and patent...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/sat-out-gilead-sciences-rally-here-is-what-holders-saw","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/sat-out-gilead-sciences-rally-here-is-what-holders-saw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBB","LU2324357040.USD","LU0114720955.EUR","BK4566","BK4139","LU0234570918.USD","BK4568","LU1934455277.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU2087621335.USD","LU0889565916.HKD","LU1571399168.USD","LU0965509101.SGD","IBBQ","IE00B3T34201.USD","LU1674673691.USD","BIB","BK4585","IE0002270589.USD","LU0859254822.USD","SG9999015945.SGD","LU1037948897.HKD","LU2468319806.SGD","BK4588","TBXU","TMED","IE00B19Z3581.USD","LU1934455863.HKD","LU0109394709.USD","SG9999015978.USD","BMED","BK4550","BK4583","LU1778281490.HKD","LU2357627491.SGD","LU2089984988.USD","LU1023059063.AUD","MEDI","GILD","BBH","LU1585245621.USD","LU1057294990.SGD","BK4578","IE00B7SZLL34.SGD","SG9999015952.SGD","LU0823416689.USD","LU1066051498.USD","LU1037948541.HKD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675180922","title":"Novartis AG Rises Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2675180922","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675180922?lang=en_us&edition=fundamental","pubTime":"2026-10-13 00:15","pubTimestamp":1791821700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 0.7% to CHF119.96 Monday on what proved to be an overall positive trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.7% to 13,877.84.Novartis AG closed CHF12.72 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 2,107,041, compared to the 50-day average trading volume of 2,892,901.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0211331839.USD","LU0070302665.USD","BK4007","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","NVS","IE0002141913.USD","IE00B2B36J28.USD","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4578","BK4585","LU0208291251.USD","MEDX","BK4588","PPH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674973806","title":"Gilead Sciences' Yeztugo Survey Supports Long-Term Growth Outlook, BofA Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2674973806","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674973806?lang=en_us&edition=fundamental","pubTime":"2026-10-12 23:07","pubTimestamp":1791817629,"startTime":"0","endTime":"0","summary":"Gilead Sciences' (GILD) HIV prevention drug Yeztugo's long-term growth outlook is supported by a physician survey, BofA Securities said in a Monday note.The investment firm said a Q3 survey of 35 heal","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4583","IE00B7SZLL34.SGD","LU0058720904.USD","SG9999015986.USD","IE0002270589.USD","MEDI","LU1061106388.HKD","LU1585245621.USD","LU0859254822.USD","BK4550","LU1934455863.HKD","LU0861579265.USD","LU0234570918.USD","BK4532","LU0965509010.AUD","LU2087621335.USD","IBBQ","TMED","LU1037948541.HKD","LU2468319806.SGD","LU1674673428.USD","LU1430594728.SGD","LU1066053197.SGD","BBH","BK4588","IE00B19Z3B42.SGD","LU2089984988.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0965508806.USD","BMED","LU0889565916.HKD","IE00B19Z3581.USD","LU1839511570.USD","BK4585","LU0320765992.SGD","BIB","TBXU","LU1674673691.USD","BK4578","LU0965509283.SGD","BK4139","SG9999015978.USD","LU2357627491.SGD","GILD","IBB","SG9999015945.SGD","LU1057294990.SGD","LU1778281490.HKD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674278877","title":"Novartis Has Levers to Pull to Offset Next Patent Cliff","url":"https://stock-news.laohu8.com/highlight/detail?id=2674278877","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674278877?lang=en_us&edition=fundamental","pubTime":"2026-10-12 20:16","pubTimestamp":1791807360,"startTime":"0","endTime":"0","summary":"1215 GMT - Novartis faces a patent cliff in the early 2030s, when three big drugs are due to lose exclusivity, but has levers to pull to offset the hit, Bank of America analysts say in a research note. Recent trial setbacks have put upcoming patent expirations for anti-inflammatory drug Cosentyx, breast-cancer medicine Kisqali, and multiple-sclerosis treatment Kesimpta on investors' radar, the analysts say. The Swiss drugmaker could address the shortfall through faster sales growth from leukemia drug Scemblix, cholesterol-lowering medication Leqvio and prostate-cancer therapy Pluvicto, as well as expanding Rhapsido to new indications, according to Bank of America. Other drugs Novartis is developing--such as blood thinner abelacimab, ianalumab for Sjogren's disease, and blood-cancer treatment pelabresib--could also help, the analysts add. Shares rise 0.5%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","LU0053666078.USD","LU0070302665.USD","LU0648001328.SGD","TFNS","LU1201861249.SGD","LU1880398471.USD","IE00BLSP4452.SGD","LU0211331839.USD","UYG","BK4585","IE00BZ1G4Q59.USD","IYG","BAC","LU0130517989.USD","LU1880398554.USD","LU0128525689.USD","LU0149725797.USD","LU0314106906.USD","LU1035773651.USD","LU0640476718.USD","IE0001KFT4U8.USD","XLF","LU1718418525.SGD","IE00BLSP4239.USD","MEDX","KBWB","VFH","PPH","BK4578","IE00B4R5TH58.HKD","LU1496350502.SGD","LU0320765489.SGD","LU0310800965.SGD","NVS","LU0321505439.SGD","LU1280957306.USD","BK4532","LU1496350171.SGD","FNCL","IYF","LU1201861165.SGD","FTXO","LU0203345920.USD","LU0320765646.SGD","LU1366192091.USD","BK4559","LU2129689605.HKD","IE00BFTCPJ56.SGD","LU1506573853.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674614538","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2674614538","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674614538?lang=en_us&edition=fundamental","pubTime":"2026-10-10 04:34","pubTimestamp":1791578040,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 2.77% to $151.17 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.59% to 7,811.54 and the Dow Jones Industrial Average  rising 0.83% to 51,654.95.This was the stock's third consecutive day of gains.Gilead Sciences Inc. closed 3.89% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  rose 1.93% to $261.44, Pfizer Inc.  rose 1.65% to $28.28, and Abbott Laboratories  rose 1.13% to $99.60.Trading volume  remained 643,432 below its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU0882574055.USD","BK4568","IE00B19Z3581.USD","BK4585","LU1037948897.HKD","LU1839511570.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD","LU1023059063.AUD","BK4583","LU1674673691.USD","LU0122379950.USD","TBXU","GILD","LU0965509101.SGD","LU1934455863.HKD","BK4588","IE0002270589.USD","SG9999015986.USD","LU0965508806.USD","IBB","SG9999015952.SGD","BK4532","LU2468319806.SGD","LU0114720955.EUR","LU1934455194.USD","SG9999015945.SGD","LU1061106388.HKD","LU2089984988.USD","LU1066053197.SGD","LU0823416689.USD","LU1934455277.USD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU1066051498.USD","BK4578","BBH","LU2112291526.USD","LU1057294990.SGD","BK4550","BMED","LU2087621335.USD","LU2324357040.USD","SG9999015978.USD","LU0889565916.HKD","LU0289739699.SGD","LU1430594728.SGD","LU0234570918.USD","LU0861579265.USD","IE00B19Z3B42.SGD","LU0109394709.USD","IE00BSNM7G36.USD","LU1585245621.USD","LU0320765992.SGD","LU1571399168.USD","BK4566","MEDI","TMED","BK4139","LU0058720904.USD","LU0859254822.USD","IBBQ","LU1778281490.HKD","LU0965509283.SGD","BIB","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865807","title":"Novartis AG Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674865807?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:15","pubTimestamp":1791562500,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 1.2% to CHF119.10 Friday on what proved to be an overall favorable trading session for the stock market, with the Swiss Market Index SMI Index  rising 1.1% to 13,787.40.Novartis AG closed CHF13.58 below its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 1,766,823, compared to the 50-day average trading volume of 2,902,065.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","MEDX","BK4588","IE0002141913.USD","PPH","LU0208291251.USD","LU0070302665.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4578","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK4007","IE00BJJMRZ35.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062420","title":"Argenx Stock Sinks as Scrapped Vyvgart Trial Erases $3.5 Billion Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062420?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:43","pubTimestamp":1791474180,"startTime":"0","endTime":"0","summary":"Argenx was recently dubbed a high-risk, high-reward \"moonshot\" biotech stock, offering investors tremendous upside if clinical trials panned out. On Thursday, investors saw the flip side of that scena","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1863844749.USD","UBS","LU3187612489.SGD","BK4007","IE00BJJMRZ35.SGD","NVS","BK4534","FMED","BK4505","LU0211331839.USD","BK4588","IE0009355771.USD","LU0823416689.USD","TBXU","LU0109394709.USD","LU2324357040.USD","BK4585","IE0034235188.USD","IE00BJT1NW94.SGD","LU0390134368.USD","BK4139","LU0208291251.USD","IBB","LU0889565916.HKD","MEDX","LU0320765489.SGD","BK4532","IE00BFTCPJ56.SGD","BK4578","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0002141913.USD","BK4118","LU0070302665.USD","LU1829250122.USD","ARGX","IE0034235071.USD","LU1983260115.SGD","LU1863844665.USD","PPH","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673483150","title":"Moderna Inc. Stock Rises 4.8%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673483150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673483150?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:33","pubTimestamp":1791405180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 4.8% to $196.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,538.69 and Dow Jones Industrial Average falling 0.7% to 51,179.87.Moderna Inc. closed 7.4% short of its 52-week high of $212.22, which the company achieved on October 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $258.45, Pfizer Inc. rose 1.8% to $28.00, and Gilead Sciences Inc. rose 1.82% to $146.85.Trading volume totaled 14.6 million, compared to the 50-day average of 20.7 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","GILD","IE00BKVL7J92.USD","SG9999015986.USD","BK4548","LU0823416689.USD","BK4501","IDNA","TBXU","BMED","BK4588","LU1778281490.HKD","MRNA","LU0861579265.USD","SG9999015952.SGD","LU2324357040.USD","LU0965509010.AUD","IE00B19Z3581.USD","BK4583","LU0965508806.USD","LU2112291526.USD","IE00BZ1G4Q59.USD","MRNX","BK4566","LGHT","IE0002270589.USD","LU1061106388.HKD","IBB","MEDI","LU2089984988.USD","BIB","LU0058720904.USD","WDNA","BK4534","IE00B7SZLL34.SGD","TMED","IBBQ","BK4578","LU1839511570.USD","IE00BSNM7G36.USD","BK4551","IE00B3T34201.USD","GNOM","BK4550","BK4585","LU0109394709.USD","LU0289739699.SGD","MRNY","SG9999015978.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011172","title":"Novartis AG Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011172?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:15","pubTimestamp":1791389700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 2.4% to CHF120.02 Wednesday on what proved to be an overall favorable trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.1% to 13,808.42.Novartis AG closed CHF12.66 short of its 52-week high of CHF132.68, which the company reached on September 3, 2026.Trading volume was 3,253,228, compared to the 50-day average trading volume of 2,851,011.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","PPH","NVS","BK4588","BK4585","MEDX","BK4578","LU0070302665.USD","LU0208291251.USD","IE0009355771.USD","IE0002141913.USD","BK4532","BK4007","LU0320765489.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0211331839.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","MEDX","RSPH","MEDI","BBP","LU0208291251.USD","SYNB","TBXU","LU0320765489.SGD","IYH","BMED","PPH","IDNA","IE00B2B36J28.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","GNMX","GDOC","IE0002141913.USD","FRTY","MRNY","PSCH","BK4007","LABU","TECB","XLVX","NVS","BK4585","NVIB","LU0211331839.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4532","MRNX","IBB","IE00BJT1NW94.SGD","LFSC","BK4588","BK4578","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673873090","title":"J.P. Morgan Remains a Buy on Gilead Sciences (GILD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673873090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673873090?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:37","pubTimestamp":1791373071,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Chris Schott maintained a Buy rating on Gilead Sciences today and set a price target of $170.00. Schott covers the Healthcare s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-gilead-sciences-gild-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-gilead-sciences-gild-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2324357040.USD","LU1778281490.HKD","LU1791710582.SGD","BIB","IBBQ","IE00BZ1G4Q59.USD","LU2133065610.SGD","LU1066051498.USD","LU0912757837.SGD","KBWB","LU2028103732.USD","TBXU","LU0882574139.USD","XBI","SG9999015978.USD","LU0859254822.USD","BK4583","LU0098860793.USD","BBH","IAI","BK4568","BK4504","LU1934455194.USD","LU0882574055.USD","IE00BKVL7J92.USD","LU1571399168.USD","IE00B19Z3581.USD","BK4578","LU1674673691.USD","LU1989772840.SGD","XLV","LU1934455277.USD","MEDI","LU0889565916.HKD","LU1934455863.HKD","BK4585","LU0114720955.EUR","LU0267386448.USD","LU1064131342.USD","BK4588","BMED","LU1548497426.USD","LU0234570918.USD","TMED","LABU","LU1244550221.USD","IBB","GILD","LU0965509010.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673492067","title":"Gilead : JP Morgan Raises Target Price to $170 from $160","url":"https://stock-news.laohu8.com/highlight/detail?id=2673492067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673492067?lang=en_us&edition=fundamental","pubTime":"2026-10-07 12:19","pubTimestamp":1791346754,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T08V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","BK4578","LU0889565916.HKD","TMED","BK4566","BBH","BK4139","LU0320765992.SGD","LU1674673428.USD","LU2468319806.SGD","BK4583","LU0058720904.USD","LU0965508806.USD","LU1066053197.SGD","LU1061106388.HKD","LU0882574055.USD","LU1037948541.HKD","LU0861579265.USD","LU2089984988.USD","BIB","LU1674673691.USD","BMED","SG9999015986.USD","LU2324357040.USD","LU1934455863.HKD","LU0122379950.USD","TBXU","IBB","LU1934455277.USD","IBBQ","IE0002270589.USD","LU0823416689.USD","IE00BSNM7G36.USD","LU1778281490.HKD","GILD","IE00B3T34201.USD","BK4588","LU2087621335.USD","BK4585","LU1430594728.SGD","LU0289739699.SGD","LU2357627491.SGD","MEDI","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","SG9999015952.SGD","LU1037948897.HKD","LU1023059063.AUD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673057189","title":"Novartis price target lowered to $156 from $170 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2673057189","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673057189?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:50","pubTimestamp":1791301814,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Thibault Boutherin lowered the firm’s price target on Novartis (NVS) to $156 from $170 and keeps an Overweight rating on the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-price-target-lowered-to-156-from-170-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-price-target-lowered-to-156-from-170-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","LU0211331839.USD","MEDX","NVS","IE00BJT1NW94.SGD","LU0070302665.USD","BK4588","LU0208291251.USD","BK4532","PPH","IE0002141913.USD","IE00B2B36J28.USD","BK4007","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4578","BK4585","IE00BJJMRZ35.SGD","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051269","title":"Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051269","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051269?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:29","pubTimestamp":1791293347,"startTime":"0","endTime":"0","summary":"Cognizant Technology Solutions  said Tuesday that it has signed a five-year extension agreement with Gilead Sciences  to support DevOps capabilities and the use of agentic artificial intelligence tools for certain technology programs.Cognizant said the updated scope will focus on uses intended to simplify processes, improve delivery, and help Gilead conduct priority technology programs more efficiently.Shares of Cognizant and Gilead were up 1.9% and 0.2% respectively in premarket activity Tuesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765992.SGD","LU2468319806.SGD","LU2506951958.HKD","LU0536402901.SGD","LU2506951875.HKD","BK4578","GILD","SG9999015945.SGD","SG9999015952.SGD","IBB","LU1057294990.SGD","LU0702159699.USD","MEDI","BIB","BK4583","IBBQ","LU1267930656.SGD","SG9999015978.USD","LU0889565916.HKD","BBH","LU0950375773.USD","LU0965509101.SGD","LU1674673691.USD","LU2506952170.USD","LU1166156734.SGD","LU0072462343.USD","TMED","TBXU","LU1674673428.USD","LU0058720904.USD","LU1037948541.HKD","AIPO","BMED","CHAT","LU0109394709.USD","LU0965509010.AUD","LU0006061336.USD","AGIX","LU1048596156.SGD","LU1066053197.SGD","ARTY","BK4134","LU1061106388.HKD","LU2087621335.USD","QTOC","LU0823416689.USD","VTHR","LU0882574055.USD","CTSH","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051186","title":"Cognizant announces five-year extension of its work with Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051186","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051186?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:13","pubTimestamp":1791292389,"startTime":"0","endTime":"0","summary":"Cognizant (CTSH) announced a five-year extension of its work with Gilead Sciences (GILD). Under the agreement, Cognizant will support Gilead’s cont...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cognizant-announces-five-year-extension-of-its-work-with-gilead-sciences-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cognizant-announces-five-year-extension-of-its-work-with-gilead-sciences-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4134","LU0965509010.AUD","CTSH","LU0231203729.USD","LU0861579265.USD","LU1934455863.HKD","LU2324357040.USD","LU1057294990.SGD","SG9999015952.SGD","LU1430594728.SGD","BMED","LU1778281490.HKD","BIB","LU0965509283.SGD","LU0702159343.USD","LU1571399168.USD","LU0950375773.USD","TMED","LU1048596156.SGD","LU2089984988.USD","LU1585245621.USD","LU1066051498.USD","BK4588","LU1037948897.HKD","LU0889565916.HKD","LU1934455277.USD","MEDI","BBH","BK4578","LU1805238398.USD","LU0708995666.HKD","LU1048588211.SGD","IBBQ","LU0006061336.USD","IE00BSNM7G36.USD","IBB","LU2468319806.SGD","SG9999015945.SGD","LU0965509101.SGD","LU0702159699.USD","BK4550","IE00BKVL7J92.USD","LU0289739699.SGD","LU0320765992.SGD","SG9999015978.USD","LU1023059063.AUD","GILD","LU0234570918.USD","LU0058720904.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673059715","title":"Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673059715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673059715?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:00","pubTimestamp":1791291624,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA6LBGRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BMED","GILD","LU1934455277.USD","BK4568","IE0002270589.USD","LU1805238398.USD","BBH","BIB","LU2468319806.SGD","IE00BKVL7J92.USD","LU0823416689.USD","SG9999015986.USD","SG9999015952.SGD","BK4578","IE00BZ1G4Q59.USD","SG9999015978.USD","LU2089984988.USD","TMED","LU0965509010.AUD","LU1430594728.SGD","LU1102505762.USD","LU1934455194.USD","LU2506952170.USD","MEDI","LU0861579265.USD","SG9999015945.SGD","BK4585","BK4583","LU0708995666.HKD","LU1023059063.AUD","LU1839511570.USD","LU0006061336.USD","LU1267930656.SGD","BK4532","LU0122379950.USD","CTSH","LU0965509101.SGD","LU0702159343.USD","LU0289739699.SGD","IBBQ","LU0950375773.USD","BK4139","LU0823417737.USD","LU1066053197.SGD","LU2112291526.USD","LU0823417653.USD","TBXU","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673056512","title":"Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056512","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056512?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:03","pubTimestamp":1791288212,"startTime":"0","endTime":"0","summary":"Entera Bio appoints ex-Gilead executive Laura Hamill to board of directorsEntera Bio named former Gilead EVP Laura Hamill to its board, effective Dec. 1, 2026.Hamill brings 35+ years in global commerc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL2M8X8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","LU1571399168.USD","LU1934455277.USD","TMED","IE00BZ1G4Q59.USD","LU0234570918.USD","LU0882574055.USD","LU1934455863.HKD","IBBQ","IE00B3T34201.USD","LU1839511570.USD","ENTX","MEDI","IE00B7SZLL34.SGD","LU0122379950.USD","LU0889565916.HKD","LU1037948541.HKD","BK4588","LU1037948897.HKD","BMED","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0320765992.SGD","LU1430594728.SGD","LU0859254822.USD","IBB","LU0823416689.USD","LU0965509283.SGD","LU1066051498.USD","LU1674673428.USD","LU2324357040.USD","SG9999015945.SGD","BK4583","LU2357627491.SGD","LU0109394709.USD","BK4578","LU1585245621.USD","LU1061106388.HKD","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455194.USD","IE0002270589.USD","SG9999015952.SGD","TBXU","GILD","IE00B19Z3581.USD","BBH","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084939","title":"Moderna Inc. Stock Rises 6.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084939","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084939?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:33","pubTimestamp":1791232380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 6.9% to $203.21 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90.This was the stock's second consecutive day of gains.Moderna Inc. closed 2.7% below its 52-week high of $208.90, which the company reached on September 29th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.2% to $252.93, Pfizer Inc. fell 1.4% to $27.41, and Gilead Sciences Inc. fell 0.08% to $144.63.Trading volume totaled 18.8 million, compared to the 50-day average of 20.1 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","LU0965509101.SGD","SG9999015945.SGD","LU2087621335.USD","BK4551","TBXU","GILD","IE00B19Z3B42.SGD","LU0965509010.AUD","BK4583","LU1057294990.SGD","LU1061106388.HKD","MRNY","SG9999015952.SGD","LU1934455277.USD","TMED","MRNA","MRNX","BMED","BK4568","BK4533","BK4585","IE00B7SZLL34.SGD","BK4139","IBBQ","BIB","LU0823416689.USD","BK4532","WDNA","BK4578","LU2112291526.USD","LU0234570918.USD","LU1674673428.USD","LU1778281490.HKD","LU0861579265.USD","IDNA","IBB","BK4588","IE00BZ1G4Q59.USD","LU1066051498.USD","LU2324357040.USD","LU1037948897.HKD","MEDI","BBH","BK4566","GNOM","LU1674673691.USD","LGHT","LU1839511570.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085063","title":"Novartis AG Rises Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085063","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085063?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:15","pubTimestamp":1791216900,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  rose 0.1% to CHF116.48 Monday on what proved to be an overall favorable trading session for the stock market, with the Swiss Market Index SMI Index  rising 0.3% to 13,703.53.Novartis AG closed CHF16.20 below its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 2,407,594, compared to the 50-day average trading volume of 2,856,042.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765489.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4578","IE00BFTCPJ56.SGD","BK4585","MEDX","IE0002141913.USD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","IE0009355771.USD","NVS","BK4007","LU0211331839.USD","IE00BJT1NW94.SGD","BK4532","PPH","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673908348","title":"Analysts’ Top Healthcare Picks: Novartis (NVS), Crescent Biopharma (CBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673908348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673908348?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:40","pubTimestamp":1791211208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Novartis (NVS) and Crescent Biopharma (CBIO) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-novartis-nvs-crescent-biopharma-cbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","CBIO","LU0070302665.USD","MEDX","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","BK4588","XBI","BK4532","BK4581","LABU","HCSG","IE0009355771.USD","LU0029874061.USD","LU0208291251.USD","LU0128526141.USD","BK4137","IE00BFTCPJ56.SGD","BK4139","LU0320765489.SGD","PPH","XLV","NVS","BK4578","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}